Cargando…

Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?

SUMMARY: The volume of the hippocampus is reduced in patients with schizophrenia, and this deficit tends to become more pronounced with chronicity. Newer antipsychotics may protect against the progressive reductions in hippocampal volume while preliminary data offer hope that specific antipsychotics...

Descripción completa

Detalles Bibliográficos
Autor principal:	Frangou, Sophia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal College of Psychiatrists 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995174/ https://www.ncbi.nlm.nih.gov/pubmed/27703789 http://dx.doi.org/10.1192/bjpo.bp.116.002857

Ejemplares similares

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT(1A) Receptor Agonist for the Treatment of Schizophrenia
por: Xiao, Guangqing, et al.
Publicado: (2022)

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT(1A) Receptor Partial Agonist/5-HT(6) Receptor Full Agonist
por: Liu, Wen-Gang, et al.
Publicado: (2021)

The Effect of Serotonin-Targeting Antidepressants on Neurogenesis and Neuronal Maturation of the Hippocampus Mediated via 5-HT1A and 5-HT4 Receptors
por: Segi-Nishida, Eri
Publicado: (2017)

Cognitive Function in Early Onset Schizophrenia: A Selective Review
por: Frangou, Sophia
Publicado: (2010)

Protective Effects of 5-HT1A Receptor Inhibition and 5-HT2A Receptor Stimulation Against Streptozotocin-Induced Apoptosis in the Hippocampus
por: Shahidi, Siamak, et al.
Publicado: (2019)

A single channel mutation alters agonist efficacy at 5-HT(3)A and 5-HT(3)AB receptors
por: Thompson, A J, et al.
Publicado: (2013)

Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation
por: Wong, Banny S, et al.
Publicado: (2010)

Dibenzofuranylethylamines as 5-HT(2A/2C) Receptor Agonists
por: Yempala, Thirumal, et al.
Publicado: (2020)

Lasmiditan mechanism of action – review of a selective 5-HT(1F) agonist
por: Clemow, David B., et al.
Publicado: (2020)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

Prediction of Efficacy of Vabicaserin, a 5-HT(2C) Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model
por: Liu, J, et al.
Publicado: (2014)

Effect of Selective 5-HT6R Agonist on Expression of 5-HT Receptor and Neurotransmitter in Vascular Dementia Rats
por: Yu, Haining, et al.
Publicado: (2017)

Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia
por: Terzić, Tea, et al.
Publicado: (2015)

5-HT1A and 5-HT2A Signaling, Desensitization, and Downregulation: Serotonergic Dysfunction and Abnormal Receptor Density in Schizophrenia and the Prodrome
por: Kim, Sun A
Publicado: (2021)

Enhancement by Hydrogen Peroxide of Calcium Signals in Endothelial Cells Induced by 5-HT1B and 5-HT2B Receptor Agonists
por: Avdonin, Pavel V., et al.
Publicado: (2019)

Review: 5-HT(1), 5-HT(2), 5-HT(3) and 5-HT(7) Receptors and their Role in the Modulation of Pain Response in the Central Nervous System
por: Cortes-Altamirano, Jose Luis, et al.
Publicado: (2018)

Effect of 5-HT(1A) Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
por: Yamada, Risa, et al.
Publicado: (2023)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

Individualized functional targeting for rTMS: A powerful idea whose time has come?
por: Vila‐Rodriguez, Fidel, et al.
Publicado: (2021)

Effect of TAAR1/5-HT(1A) agonist SEP-363856 on REM sleep in humans
por: Hopkins, Seth C., et al.
Publicado: (2021)

Yokukansan Increases 5-HT(1A) Receptors in the Prefrontal Cortex and Enhances 5-HT(1A) Receptor Agonist-Induced Behavioral Responses in Socially Isolated Mice
por: Ueki, Toshiyuki, et al.
Publicado: (2015)

Synergistic Effect between Maternal Infection and Adolescent Cannabinoid Exposure on Serotonin 5HT(1A) Receptor Binding in the Hippocampus: Testing the “Two Hit” Hypothesis for the Development of Schizophrenia
por: Dalton, Victoria S., et al.
Publicado: (2012)

European Psychiatry 2020: Moving forward
por: Fiorillo, Andrea, et al.
Publicado: (2020)

5-HT(2A) Agonists: A Novel Therapy for Functional Neurological Disorders?
por: Bryson, Alexander, et al.
Publicado: (2017)

Chronic Administration of 5-HT1A Receptor Agonist Relieves Depression and Depression-Induced Hypoalgesia
por: Jiang, Zhao-Cai, et al.
Publicado: (2014)

Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis
por: Mori, Masayoshi, et al.
Publicado: (2014)

Crystal structure of the human 5-HT(1B) serotonin receptor bound to an inverse agonist
por: Yin, Wanchao, et al.
Publicado: (2018)

Effects of (−)‐MBP, a novel 5‐HT(2C) agonist and 5‐HT(2A/2B) antagonist/inverse agonist on brain activity: A phMRI study on awake mice
por: Sathe, Preeti K., et al.
Publicado: (2023)

Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms
por: Huang, Xuefei, et al.
Publicado: (2017)

Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease
por: Neumann, Joachim, et al.
Publicado: (2023)

Pharmacokinetics of DA-6886, A New 5-HT(4) Receptor Agonist, in Rats
por: Lee, Dae Young, et al.
Publicado: (2022)

Identification of a Potent and Selective 5-HT(1A) Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity
por: Linciano, Pasquale, et al.
Publicado: (2020)

Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications
por: Shahar, Orr, et al.
Publicado: (2022)

Polymorphic Variations in 5-HT2A, 5-HTT and DISC 1 in First Episode Schizophrenia Patients
por: González, L. Medina
Publicado: (2009)

Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT(2) and 5-HT(1) Receptors
por: van Wel, Janelle H. P., et al.
Publicado: (2012)

The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
por: Vegas‐Suárez, Sergio, et al.
Publicado: (2021)

Role of peripheral 5-HT(5A) receptors in 5-HT-induced cardiac sympatho-inhibition in type 1 diabetic rats
por: García-Pedraza, José Ángel, et al.
Publicado: (2020)

Electroacupuncture improves synaptic plasticity by regulating the 5-HT1A receptor in hippocampus of rats with chronic unpredictable mild stress
por: Chen, Lixing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j5frs14n949gqsm62ntod0aedu